abstract |
The present disclosure particularly provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, which is a modulator of the C5a receptor. Also provided are pharmaceutical compositions and methods of use and non-pharmaceutical applications comprising the treatment of a disease or disorder involving pathological activation from C5a: |